Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Telomir Pharmaceuticals, Inc. (TELO) had Weighted-Average Shares Outstanding (Diluted) of 29.54M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-16.53M |
|
-- |
|
-- |
|
$12.24M |
|
$-12.24M |
|
$-4.29M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-12.24M |
|
$-7.90M |
|
29.54M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
29.54M |
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$1.32M |
|
-- |
|
-- |
|
$1.32M |
|
$0.68M |
|
-- |
|
-- |
|
$0.68M |
|
$0.64M |
|
$0.64M |
|
$0.64M |
|
29.76M |
|
| Cash Flow Statement Financials | |
$-5.07M |
|
-- |
|
$6.34M |
|
$0.00M |
|
$1.27M |
|
$1.26M |
|
$6.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2571.03% |
|
-2571.04% |
|
-1248.69% |
|
-2571.04% |
|
$0.02 |
|
$-0.17 |
|
$-0.17 |
|